| 1 |
35563245 | Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder? | 2022 Apr 27 |
2 |
| 2 |
35568060 | Effect of anti-iduronidase sulfatase in patients with Mucopolysaccharidosis type II treated with enzyme replacement therapy. | 2022 May 11 |
2 |
| 3 |
33488893 | Dysostosis in mucopolysaccharidosis type 2: A case of longitudinal follow up and literature review. | 2021 Mar |
1 |
| 4 |
33781915 | Iduronate-2-sulfatase fused with anti-hTfR antibody, pabinafusp alfa, for MPS-II: A phase 2 trial in Brazil. | 2021 Jul 7 |
6 |
| 5 |
33960103 | Genotype-phenotype studies in a large cohort of Brazilian patients with Hunter syndrome. | 2021 Sep |
2 |
| 6 |
34289859 | A review of the clinical outcomes in idursulfase-treated and untreated Filipino patients with mucopolysaccharidosis type II: data from the local lysosomal storage disease registry. | 2021 Jul 21 |
4 |
| 7 |
34670126 | Identification and structure characterization of novel IDS variants causing mucopolysaccharidosis type II: A retrospective analysis of 30 Chinese children. | 2021 Dec |
1 |
| 8 |
34830113 | Loss of Function of Mutant IDS Due to Endoplasmic Reticulum-Associated Degradation: New Therapeutic Opportunities for Mucopolysaccharidosis Type II. | 2021 Nov 12 |
1 |
| 9 |
30595526 | Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 Trial. | 2019 Feb 6 |
2 |
| 10 |
31022913 | Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles. | 2019 Apr 24 |
3 |
| 11 |
29289480 | Chaperone effect of sulfated disaccharide from heparin on mutant iduronate-2-sulfatase in mucopolysaccharidosis type II. | 2018 Feb |
1 |
| 12 |
29580682 | Dose-Dependent Prevention of Metabolic and Neurologic Disease in Murine MPS II by ZFN-Mediated In Vivo Genome Editing. | 2018 Apr 4 |
1 |
| 13 |
29671225 | Effectiveness of Early Hematopoietic Stem Cell Transplantation in Preventing Neurocognitive Decline in Mucopolysaccharidosis Type II: A Case Series. | 2018 |
1 |
| 14 |
30042467 | Shutdown of ER-associated degradation pathway rescues functions of mutant iduronate 2-sulfatase linked to mucopolysaccharidosis type II. | 2018 Jul 24 |
1 |
| 15 |
30064964 | Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS. | 2018 Sep |
1 |
| 16 |
28588666 | Molecular analysis of the novel IDS allele in a Thai family with mucopolysaccharidosis type II: The c.928C>T (p.Gln310*) transcript is sensitive to nonsense-mediated mRNA decay. | 2017 Jun |
2 |
| 17 |
28649514 | Early hematopoietic stem cell transplantation in a patient with severe mucopolysaccharidosis II: A 7 years follow-up. | 2017 Sep |
2 |
| 18 |
26051019 | A method for measuring disease-specific iduronic acid from the non-reducing end of glycosaminoglycan in mucopolysaccharidosis type II mice. | 2016 Feb |
1 |
| 19 |
26845288 | Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome). | 2016 Feb 5 |
2 |
| 20 |
27251652 | Oxidative and nitrative stress and pro-inflammatory cytokines in Mucopolysaccharidosis type II patients: effect of long-term enzyme replacement therapy and relation with glycosaminoglycan accumulation. | 2016 Sep |
2 |
| 21 |
27342998 | Amniotic fluid glycosaminoglycans in the prenatal diagnosis of mucopolysaccharidoses - A useful biomarker. | 2016 Sep 1 |
1 |
| 22 |
25622168 | [Necrotizing pneumonia associated with influenza A H1N1 infection in a child with mucopolysaccharidosis type II. Case report]. | 2015 Jan |
1 |
| 23 |
24399699 | Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome). | 2014 Jan 8 |
2 |
| 24 |
25059704 | A Hunter Patient with a Severe Phenotype Reveals Two Large Deletions and Two Duplications Extending 1.2 Mb Distally to IDS Locus. | 2014 |
1 |
| 25 |
25071396 | Guidelines for diagnosis and treatment of Hunter Syndrome for clinicians in Latin America. | 2014 Jun |
4 |
| 26 |
25231261 | Clinical efficacy of enzyme replacement therapy in paediatric Hunter patients, an independent study of 3.5 years. | 2014 Sep 18 |
1 |
| 27 |
23707223 | Extension of the molecular analysis to the promoter region of the iduronate 2-sulfatase gene reveals genomic alterations in mucopolysaccharidosis type II patients with normal coding sequence. | 2013 Sep 10 |
2 |
| 28 |
23726270 | Idursulfase enzyme replacement therapy in an adult patient with severe Hunter syndrome having a novel mutation of iduronate-2-sulfatase gene. | 2013 Aug 23 |
1 |
| 29 |
23801937 | Mucopolysaccharidosis Type II and the G374sp Mutation. | 2013 Apr |
1 |
| 30 |
24908534 | Mucopolysaccharidosis type II with inguinal hernia. | 2013 Sep |
1 |
| 31 |
23430900 | Plasmatic and Urinary Glycosaminoglycans Characterization in Mucopolysaccharidosis II Patient Treated with Enzyme-Replacement Therapy with Idursulfase. | 2012 |
1 |
| 32 |
21334454 | DNA damage in leukocytes from pretreatment mucopolysaccharidosis type II patients; protective effect of enzyme replacement therapy. | 2011 Apr 3 |
1 |
| 33 |
21605424 | Molecular analysis of iduronate -2- sulfatase gene in Tunisian patients with mucopolysaccharidosis type II. | 2011 May 23 |
1 |
| 34 |
22071845 | Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome). | 2011 Nov 9 |
2 |
| 35 |
20652491 | Characterization of a novel mucopolysaccharidosis type II mouse model and recombinant AAV2/8 vector-mediated gene therapy. | 2010 Jul |
4 |
| 36 |
18245410 | Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome). | 2008 Feb |
1 |
| 37 |
18396123 | Early response to idursulfase treatment in a 3 year-old boy affected of Hunter syndrome. | 2008 May-Jun |
1 |
| 38 |
18580692 | Initial report from the Hunter Outcome Survey. | 2008 Jul |
1 |
| 39 |
19707363 | Review of the use of idursulfase in the treatment of mucopolysaccharidosis II. | 2008 Jun |
1 |
| 40 |
17185020 | A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome). | 2007 Mar |
1 |
| 41 |
17345556 | [Clinical study of enzyme replacement therapy with idursulfase]. | 2007 Feb 19 |
2 |
| 42 |
17459751 | Preclinical dose ranging studies for enzyme replacement therapy with idursulfase in a knock-out mouse model of MPS II. | 2007 Jun |
4 |
| 43 |
17876721 | The characterization of a murine model of mucopolysaccharidosis II (Hunter syndrome). | 2007 Nov |
1 |
| 44 |
18174963 | Idursulfase in Hunter syndrome treatment. | 2007 Nov |
2 |
| 45 |
30743745 | Idursulfase: enzyme replacement therapy for mucopolysaccharidosis Type II (Hunter syndrome). | 2007 Jan |
1 |
| 46 |
12572850 | Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report. | 2002 |
5 |
| 47 |
7663435 | Expression of the two iduronate-2-sulfatase cDNAs. | 1995 Jun |
1 |
| 48 |
8244397 | Sequence of the human iduronate 2-sulfatase (IDS) gene. | 1993 Sep |
2 |